LYNX1 CAPITAL MANAGEMENT LP purchased 8.0% of their position (50.05K shares) of PASSAGE BIO, INC. on the open market
Open‑market purchase worth $206.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/29/2026ACC: 0000902664-26-002945
10% Owner
Since Aug 2024
+50.05K
Net shares
Net buyer
$206.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50.05K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value per share ("Common Stock")
Indirect
Shares
+50.05K
Price / share
$4.12
Trade value
$206.10K
% of position
8.0%
6/25/2026
623.70K→673.76K
Total
Net shares
+50.05K
Net value
$206.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value per share ("Common Stock") Indirect | 6/25/2026 | P · Purchase | +50.05K | $4.12 | $206.10K | 8.0% | 623.70K | 673.76K |
| Total | +50.05K | $206.10K | ||||||
Derivative Transactions0
No derivative transactions reported